$3.09
-0.13-4.04%
At Close: -
$3.12
0.030.97%
After Hours: Jul 19, 9:26 AM EDT
15 minutes delayed
Comments
Loading...
Sagimet Biosciences
SGMTNASDAQ
Unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Sagimet Biosciences (NASDAQ:SGMT) Stock, Analyst Ratings, Price Targets, Forecasts
Sagimet Biosciences Inc has a consensus price target of $35.8 based on the ratings of 6 analysts. The high is $67 issued by Piper Sandler on August 8, 2023. The low is $6 issued by Goldman Sachs on July 1, 2024. The 3 most-recent analyst ratings were released by Goldman Sachs, HC Wainwright & Co., and JMP Securities on July 1, 2024, June 14, 2024, and June 7, 2024, respectively. With an average price target of $28.67 between Goldman Sachs, HC Wainwright & Co., and JMP Securities, there's an implied 827.72% upside for Sagimet Biosciences Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Goldman Sachs
HC Wainwright & Co.
JMP Securities
Leerink Partners
Piper Sandler
1calculated from analyst ratings
Analyst Ratings for Sagimet Biosciences
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 07/01/2024 | Buy Now | 94.17% | Goldman Sachs | Andrea Tan | $23 → $6 | Maintains | Neutral | Get Alert |
| 06/14/2024 | Buy Now | 935.6% | HC Wainwright & Co. | Ed Arce | $32 → $32 | Reiterates | Buy → Buy | Get Alert |
| 06/07/2024 | Buy Now | 1453.4% | JMP Securities | Jonathan Wolleben | $48 → $48 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 06/07/2024 | Buy Now | 935.6% | HC Wainwright & Co. | Ed Arce | $32 → $32 | Reiterates | Buy → Buy | Get Alert |
| 05/24/2024 | Buy Now | 935.6% | HC Wainwright & Co. | Ed Arce | → $32 | Reiterates | Buy → Buy | Get Alert |
| 05/24/2024 | Buy Now | 1453.4% | JMP Securities | Jonathan Wolleben | $48 → $48 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 05/16/2024 | Buy Now | 935.6% | HC Wainwright & Co. | Ed Arce | → $32 | Reiterates | Buy → Buy | Get Alert |
| 05/16/2024 | Buy Now | 644.34% | Goldman Sachs | Andrea Tan | $27 → $23 | Maintains | Buy | Get Alert |
| 05/02/2024 | Buy Now | 935.6% | HC Wainwright & Co. | Ed Arce | → $32 | Initiates | → Buy | Get Alert |
| 03/26/2024 | Buy Now | 773.79% | Goldman Sachs | Andrea Tan | $37 → $27 | Maintains | Buy | Get Alert |
| 03/25/2024 | Buy Now | 741.42% | Leerink Partners | Thomas Smith | → $26 | Initiates | → Outperform | Get Alert |
| 02/07/2024 | Buy Now | 1388.67% | JMP Securities | Jonathan Wolleben | $47 → $46 | Maintains | Market Outperform | Get Alert |
| 01/23/2024 | Buy Now | 1097.41% | Goldman Sachs | Andrea Tan | $30 → $37 | Maintains | Buy | Get Alert |
| 01/23/2024 | Buy Now | 1421.04% | JMP Securities | Jonathan Wolleben | $31 → $47 | Maintains | Market Outperform | Get Alert |
| 01/22/2024 | Buy Now | 1421.04% | JMP Securities | Jonathan Wolleben | $31 → $47 | Maintains | Market Outperform | Get Alert |
| 12/05/2023 | Buy Now | 903.24% | JMP Securities | Jonathan Wolleben | → $31 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 08/08/2023 | Buy Now | — | TD Cowen | Ritu Baral | — | Initiates | → Outperform | Get Alert |
| 08/08/2023 | Buy Now | 2068.28% | Piper Sandler | Yasmeen Rahimi | → $67 | Initiates | → Overweight | Get Alert |
| 08/08/2023 | Buy Now | 870.87% | JMP Securities | Jonathan Wolleben | → $30 | Initiates | → Market Outperform | Get Alert |
| 08/08/2023 | Buy Now | 967.96% | Goldman Sachs | Andrea Tan | → $33 | Initiates | → Buy | Get Alert |
FAQ
What is the target price for Sagimet Biosciences (SGMT) stock?
The latest price target for Sagimet Biosciences (NASDAQ:SGMT) was reported by Goldman Sachs on July 1, 2024. The analyst firm set a price target for $6.00 expecting SGMT to rise to within 12 months (a possible 94.17% upside). 20 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Sagimet Biosciences (SGMT)?
The latest analyst rating for Sagimet Biosciences (NASDAQ:SGMT) was provided by Goldman Sachs, and Sagimet Biosciences maintained their neutral rating.
When was the last upgrade for Sagimet Biosciences (SGMT)?
There is no last upgrade for Sagimet Biosciences
When was the last downgrade for Sagimet Biosciences (SGMT)?
There is no last downgrade for Sagimet Biosciences.
When is the next analyst rating going to be posted or updated for Sagimet Biosciences (SGMT)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Sagimet Biosciences, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Sagimet Biosciences was filed on July 1, 2024 so you should expect the next rating to be made available sometime around July 1, 2025.
Is the Analyst Rating Sagimet Biosciences (SGMT) correct?
While ratings are subjective and will change, the latest Sagimet Biosciences (SGMT) rating was a maintained with a price target of $23.00 to $6.00. The current price Sagimet Biosciences (SGMT) is trading at is $3.09, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.